Regencell Bioscience Limited (RGC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Regencell Bioscience Lim...

    NASDAQ: RGC · Real-Time Price · USD
    17.10
    0.95 (5.88%)
    At close: Oct 03, 2025, 3:59 PM
    16.99
    -0.64%
    After-hours: Oct 03, 2025, 07:45 PM EDT

    Regencell Bioscience Cash Flow Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
    Net Income
    		 -926 -926 -1.12K -1.12K -1.03K -1.03K -1.32K -1.32K -1.61K -1.61K -1.93K -1.93K -1.8K -1.8K -506.45 -506.45 -166.92 -166.92
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a 769.69K n/a n/a n/a 415.6M n/a n/a n/a n/a n/a n/a n/a
    Stock-Based Compensation
    		 140.00 140.00 135.00 135.00 100.00 100.00 n/a n/a 450.00 450.00 578.95 578.95 802.18 802.18 -7M n/a n/a n/a
    Other Working Capital
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 31.6M n/a n/a n/a 303.12 n/a n/a n/a
    Other Non-Cash Items
    		 786.81 786.81 982.00 982.61 933.31 933.31 1.31K 1.31K 1.16K 1.16K 1.35K 1.35K 993.55 993.55 n/a 506.45 n/a n/a
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.9M n/a n/a n/a -3.9M n/a n/a n/a
    Change in Working Capital
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 147.7M n/a n/a n/a 303.12 n/a n/a n/a
    Operating Cash Flow
    		 n/a n/a n/a n/a n/a n/a 1.54M n/a 450.00 450.00 -5.43B n/a n/a n/a -196.77 n/a -186.88 -186.88
    Capital Expenditures
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -575.18M n/a n/a n/a n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -9.63B n/a n/a n/a 160M n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -10.42B n/a n/a n/a n/a n/a n/a n/a
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -103.6M n/a n/a n/a -103.6M n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 22.48B n/a n/a n/a 103.6M n/a 154.01 154.01
    Financial Cash Flow
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 22.38B n/a n/a n/a n/a n/a 154.01 154.01
    Net Cash Flow
    		 n/a n/a n/a n/a n/a n/a 1.54M n/a 450.00 450.00 6.19B n/a n/a n/a -228.74M n/a n/a n/a
    Free Cash Flow
    		 n/a n/a n/a n/a n/a n/a 1.54M n/a 450.00 450.00 -6B n/a n/a n/a -189.14 n/a -194.52 -194.52

    Add to Watchlist